Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Error occurred: cannot get document summary
CDK-2 with indazole inhibitor 9 bound at its active site[TRANSFERASE]
View in iCn3D Similar StructuresPubMedProteinsConserved DomainsPubChem Compound
CDK-2 with indazole inhibitor 17 bound at its active site[TRANSFERASE/Transferase inhibitor]
Structure of CDK2 in complex with a Pyrazolo[4,3-d]pyrimidine Bioisostere of Roscovitine[TRANSFERASE/TRANSFERASE INHIBITOR]
CDK2 ternary complex with SU9516 and ANS[TRANSFERASE/TRANSFERASE INHIBITOR]
CDK2 in complex with inhibitor SU9516[TRANSFERASE/TRANSFERASE INHIBITOR]
CDK2 ternary complex with JWS648 and ANS[TRANSFERASE/TRANSFERASE INHIBITOR]
CDK2 in complex with inhibitor JWS648[TRANSFERASE/TRANSFERASE INHIBITOR]
Apo CDK2 crystallized from Jeffamine[TRANSFERASE]
CDK2 in complex with 3 molecules of 8-anilino-1-naphthalene sulfonate[TRANSFERASE]
CDK2 in complex with two molecules of 8-anilino-1-naphthalene sulfonate[TRANSFERASE]
Structure of CDK2-CYCLIN A with a Pyrazolo(4,3-h) quinazoline-3- carboxamide inhibitor[TRANSFERASE]
Optimisation of 6,6-Dimethyl Pyrrolo 3,4-c pyrazoles: Identification of PHA-793887, a Potent CDK Inhibitor Suitable for Intravenous Dosing[CELL CYCLE]
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on